The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Convergence 2021: Advocacy Successes & Challenges

ACR Convergence 2021: Advocacy Successes & Challenges

October 25, 2021 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR’s advocacy efforts over the past year have helped bring to Congress important legislation that could have effects felt by clinics and patients around the country, but there is plenty of work ahead to push the measures across the finish line.

You Might Also Like
  • ACR Convergence 2020: From Clinic to Capitol Hill Session Offers Insights into Advocacy, Regulatory Issues
  • Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session
  • Opening Session of ACR Convergence 2021 Takes on Burnout, Pandemic Challenges & Moving Toward a New Normal
Also By This Author
  • Year in Review: Rheumatic Disease Research in 2019

Leaders in government affairs for the ACR will describe this progress and needed efforts in an ACR Convergence 2021 session, Make Your Voice Count: Annual Advocacy Update, scheduled for Sunday, Nov. 7, at 11 a.m. EST.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The session will be moderated by Ryan Jessee, MD, a member of the ACR’s Government Affairs Committee (GAC) and clinical associate professor of rheumatology at Duke University School of Medicine, Durham, N.C. GAC Chair Elizabeth (Blair) Solow, MD, will talk about the strides made over the past year. Amanda Wiegrefe, the ACR director of regulatory affairs, and Lennie McDaniel, JD, the ACR director of congressional affairs, will discuss legislative challenges the College will face in the coming year. Amy Barron, RN, will discuss advocacy from a patient’s perspective, and Daniel Redinger, the ACR’s manager of advocacy and political affairs, will give attendees an “advocacy toolkit,” a basic how-to for driving policy changes meaningful to rheumatologists and patient care.

“This is a chance to celebrate our achievements as well as let people know about upcoming challenges,” Dr. Jessee says, “and then also educate members on ways, both big and small, in which they can become involved and help their profession as well as themselves from an advocacy standpoint.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The patient’s perspective is a new addition to the annual session. “We wanted to broaden the appeal and make it clear to everyone that advocacy is something that’s done not just by providers, but patients as well,” Dr. Jessee says. “Most of our issues affect providers and patients, whether it’s access to care or being able to afford medications or see the provider you need.”

Legislative Highlights

Ms. McDaniel says the biggest advocacy accomplishment over the past year was the reintroduction of the Improving Seniors’ Timely Access to Care Act, which puts up guardrails to safeguard care that might be threatened by prior authorization requirements that force a physician to get insurer authorization before treatment can be given to a patient. Too often, she says, this process results in patients going to the pharmacy for a medication “and finding out that they can’t pick it up because the prior authorization hasn’t gone through.” This frequently leads to delays in treatment and, sometimes, in patients never getting their medication at all because they find the process too burdensome.

Pages: 1 2 | Single Page

Filed Under: ACR Convergence, Legislation & Advocacy, Meeting Reports Tagged With: ACR advocacy, ACR Convergence 2021, Legislation & Advocacy, prior authorization, Ryan Jessee

You Might Also Like:
  • ACR Convergence 2020: From Clinic to Capitol Hill Session Offers Insights into Advocacy, Regulatory Issues
  • Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session
  • Opening Session of ACR Convergence 2021 Takes on Burnout, Pandemic Challenges & Moving Toward a New Normal
  • ACR’s 2017 Advocacy Successes

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)